Kidney Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be 18 years of age or older
- You have been diagnosed with a specific type of kidney cancer called clear cell renal cell carcinoma, confirmed through a tissue sample test
- Your cancer has spread to other parts of the body (advanced or metastatic stage)
- You are about to begin your first round of treatment for this advanced kidney cancer, using a type of immunotherapy (either two immunotherapy drugs together, or one immunotherapy drug combined with a targeted therapy drug)
- You are able to follow the procedures required by the study
- You are willing and able to sign a consent form agreeing to take part and to allow your data to be used (this can be done with the help of a witness if needed)
Who may not be able to join:
- You have been diagnosed with another type of cancer, either in the past or currently
- You have previously received any cancer treatments
- You have previously been treated with steroid medications
- You currently have an active viral infection, such as hepatitis C (HCV) or HIV (confirm with trial site)
- You are not able to independently follow or keep up with the study procedures required
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +39 0652666271
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Torquetenovirus in numbers of copies/ml
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.